Introduction
Warfarin is an oral anticoagulant (OAC), which is widely used in treatment and prophylaxis of thromboembolic conditions and controlled through the international normalized ratio (INR) (1, 2) . Warfarin works by blocking the gamma-glutamyl carboxylase of vitamin K-dependent coagulation factors prothrombin (factor II), factors VII, IX, X, proteins C, and S through the inhibition of the vitamin K epoxide reductase enzyme (2, 3) . To adjust the effective therapeutic dose of warfarin, the INR level should be monitored and maintained at the level of two-three (1).
The most significant adverse effect associated with warfarin is mostly spontaneous minor subcutaneous or intramuscular bleedings; nevertheless, warfarin may rarely cause intraabdominal hemorrhages with higher mortality risk (3, 4) .
Whereas decreasing the dose of OACs is effective in the treatment of minor bleedings, surgical and conservative treatment methods are preferred in case of major spontaneous intra-abdominal bleedings (2, 3 (5) . In the literature, there are the cases of hemodynamically stable patients with no additional complication other than major spontaneous intra-abdominal hemorrhage and acute abdominal pain who could be treated with conservative approach without a need for surgical intervention (3, 6) . In the literature, minor and major bleedings are classified as hemorrhage, but major hemorrhage has an intermediate patient group that is controlled by medical treatment without surgical treatment.
Here, we aimed to present a patient, who stayed hemodynamically stable despite suffering from spontaneous intra-abdominal hemorrhage and acute abdominal pain and did not develop any additional complication and, to discuss treatment methods that can be applied for such patients who are classified as the intermediate group.
Case
A 75-year-old female patient presented to the emergency department due to ecchymosis present for one week and accompanied by gradually advancing abdominal pain for the last four days (Figure 1 ). According to her medical records, the patient had hypertension (HT) and was started on warfarin therapy (posology: coumadin ® 5 mg/day) two months ago due to peripheral vascular insufficiency. However, she did not have necessary control examinations on regular basis. On admission, her arterial blood pressure was 120/60 mm/Hg, pulse rate was 80/min, respiratory rate was 18/min and body temperature was 36.3°C. Systemic examination revealed abdominal rebound and tenderness at the umblical region and ecchymosis at the medial of the left femur and left patella. The results of the laboratory tests performed on admission were as follows: white blood cell (WBC): 8.770/mm 3 Abdominopelvic computed tomography (CT) indicated significant heterogeneity in mesenteric fat planes, diffuse wall thickening in ileal segments and excessive free fluid in all peritoneal recesses (Figure 2 ). Following her written consent, the patient was hospitalized with the preliminary diagnosis of intra-abdominal hemorrhage secondary to uncontrolled warfarin therapy. Therefore, warfarin therapy was discontinued. The patient was administered vitamin K, proton pump inhibitor and two units of erythrocyte suspension, and five units of fresh frozen plasma (FFP) in addition to fluid resuscitation. On the 2 nd day of the treatment, physical examination findings of the patient disappeared. The vital findings of the patient were stable. On the 2 th day of hospitalization, the laboratory findings were as follows: WBC: 7.380/mm 3 , Hb: 8.7 g/dL, Hct: 26.6%, urea: 17.1 mg/dL, Cr: 0.64 mg/dL, aPTT: 25.3/sec, PT: 12.2/sec, and INR: 0.9. On the control abdominopelvic CT scan, there was a significant decrease in the amount of intra-abdominal fluid (Figure 3 ). On the 3 rd day of the treatments, as clinical manifestations improved, oral feeding was started and low molecular weight heparin (LMWH) (posology: clexane ® : 0.4 mL/day) was added to the medical therapy. On the 4 th day of hospitalization, the laboratory findings were as follows: WBC: 5.990/mm 3 , Hb: 9.9 g/dL, Hct: 30.7%, urea: 21.1 mg/dL, Cr: 0.62 mg/ dL, aPTT: 26.6/sec, PT: 11.8/sec and INR: 0.9. Therefore, the patient was discharged to continue the LMWH therapy with regular control examinations.
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Figure1. Skin manifestations
Figure2. Abdominopelvic computed tomography image of pretreatment
Discussion
Bleeding is the primary complication of warfarin therapy with an annual incidence of 7.6% (7). Even though warfarin-related bleeding is mostly subcutaneous or intramuscular and can be managed by reducing the dose of warfarin, there is a risk for gastrointestinal, intracranial, retroperitoneal and intraperitoneal bleeding, which can be life threatening (3, 4) . In the literature, the followings have been reported to be the factors increasing the risk for bleeding associated with warfarin usage: dose of warfarin, advanced age, ulcer, HT, cancer, cerebrovascular event, history of surgery and history of gastrointestinal bleeding (3, (7) (8) (9) . Our case was similar to the cases reported in the published literature because of her advanced age, history of HT and INR level above the therapeutic level. The INR level in our patient was above nine and beyond the measurable limits.
Acute abdominal pain may occur in patients receiving warfarin and suffering from non-traumatic intra-abdominal hemorrhage. Coagulation parameters are usually disrupted in such patients. However, it should be always kept in mind that intra-abdominal hemorrhage can develop even in the presence of normal coagulation parameters (6) . In patients presenting with acute abdominal pain, abdominal USG and CT are the most commonly preferred imaging methods employed for a definitive diagnosis. Although USG is an easily applicable method, abdominal CT has higher sensitivity (5). Abdominopelvic CT in our patient demonstrated significant heterogeneity in mesenteric fatty planes, diffuse wall thickening in ileal segments and excessive free fluid in all peritoneal recesses. Additionally, all coagulation parameters were disrupted as reported in the literature. Nevertheless, the vital signs of the patient were stable despite acute abdominal pain.
In the case of hemorrhages associated with the use of warfarin, it is generally sufficient to adjust the dose of OAC for the treatment of hemodynamically stable minor bleedings, which are not accompanied by any disorder other than skin manifestations. If vitamin K is to be added to the therapy, it should be noted that INR response may be seen 24 hours after oral intake and within four-six hours after intravenous administration (2) . In intermediate group patients, who are hemodynamically stable but having major intra-abdominal hemorrhage, conservative approach may be applied as the initial treatment. At the first phase of the treatment, relevant OAC agent is discontinued, and FFP and intravenous vitamin K are introduced. However, such patients may possibly require blood transfusion without a need for surgical intervention. Also, prothrombin complex concentrations can be used to reverse the effects of OACs if rapid INR response is desired (2, 3, 6) . Surgical intervention is required for hemodynamically unstable patients with acute abdominal pain in cases of ongoing active hemorrhage, generalized peritonitis, obstruction, acute abdomen, intestinal ischemia, and perforation (5). Nevertheless, our patient did not show any complication that may necessitate surgery. She was started oral feeding on the 2 nd day of conservative therapy and was discharged from the hospital on the 4 th day with suggestions for regular control examinations.
We believe that it is possible to successfully treat and follow up hemodynamically stable patients, who are intermediate group without using operative methods and spontaneous intra-abdominal hemorrhages may be classified as minor, intermediate, and major. However, the number of the studies -excluding the case reports -addressing the issue is limited in the published literature. Therefore, we need reports on larger series to draw more accurate conclusions. FinancialDisclosure: The authors declared this study has received no financial support
Ethics
